Leukemia & Lymphoma, Volume 60, Issue 3 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 60, Issue 3 (2019)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Volume 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Where do we currently stand with T-cell prolymphocytic leukemia?
Amit Khot
Pages: 563-565
Published online: 22 Jan 2019
First Page PreviewforWhere do we currently stand with T-cell prolymphocytic leukemia? | Full Text | References | PDF (294.1 KB) | EPUB
  • 235 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
Wilms tumor 1 expression: addressing the ‘elephant’ in MDS
Yazan F. Madanat & Mikkael A. Sekeres
Pages: 566-567
Published online: 04 Feb 2019
CitationforWilms tumor 1 expression: addressing the ‘elephant’ in MDS | Full Text | References | PDF (242.5 KB) | EPUB
  • 64 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
ASXL1 mutations in idiopathic cytopenias: determined significance?
Carlos Galvez & Brady L Stein
Pages: 568-570
Published online: 02 Oct 2018
First Page PreviewforASXL1 mutations in idiopathic cytopenias: determined significance? | Full Text | References | PDF (408 KB) | EPUB
  • 104 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
What does good FISHing look like in MDS?
Meaghan Wall & Piers Blombery
Pages: 571-572
Published online: 08 Nov 2018
CitationforWhat does good FISHing look like in MDS? | Full Text | References | PDF (343.3 KB) | EPUB
  • 68 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Review
Improving CD20 antibody therapy: obinutuzumab in lymphoproliferative disorders
Anca Prica & Michael Crump
Pages: 573-582
Published online: 22 Jan 2019
AbstractforImproving CD20 antibody therapy: obinutuzumab in lymphoproliferative disorders | Full Text | References | PDF (759.5 KB) | EPUB
  • 469 Views
  • 11 CrossRef citations
  • 0Altmetric
Review
Management of primary refractory acute myeloid leukemia in the era of targeted therapies
Christine M. McMahon & Alexander E. Perl
Pages: 583-597
Published online: 20 Sep 2018
AbstractforManagement of primary refractory acute myeloid leukemia in the era of targeted therapies | Full Text | References | PDF (1.1 MB) | EPUB
  • 539 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data
Kieran Sahasrabudhe, Mario Otto, Peiman Hematti & Vaishalee Kenkre
Pages: 598-609
Published online: 06 Sep 2018
AbstractforTCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data | Full Text | References | PDF (856.8 KB) | EPUB | Supplemental
  • 623 Views
  • 8 CrossRef citations
  • 0Altmetric

Emerging Drug Profile

Ixazomib – the first oral proteasome inhibitor
Jingmei Xie, Ning Wan, Zhuoru Liang, Tiantian Zhang & Jie Jiang
Pages: 610-618
Published online: 07 Jan 2019
AbstractforIxazomib – the first oral proteasome inhibitor | Full Text | References | PDF (1 MB) | EPUB
  • 854 Views
  • 11 CrossRef citations
  • 0Altmetric

Original Article

Article
Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients
Maria Gavriatopoulou, Despina Fotiou, Ursula Koloventzou, Maria Roussou, Magdalini Migkou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Dimitrios C. Ziogas, Ioannis Panagiotidis, Dimitra Gika, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Efstathios Kastritis & Meletios Athanasios Dimopoulos
Pages: 619-628
Published online: 10 Jan 2019
AbstractforVulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 199 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Characterization of cancer comorbidity prior to allogeneic hematopoietic cell transplantation
Christopher R. D’Angelo, Brianna Novitsky, Sang Mee Lee, Lucy A. Godley, Justin Kline, Richard A. Larson, Hongtao Liu, Olatoyosi Odenike, Wendy Stock, Michael R. Bishop & Andrew S. Artz
Pages: 629-638
Published online: 02 Aug 2018
AbstractforCharacterization of cancer comorbidity prior to allogeneic hematopoietic cell transplantation | Full Text | References | PDF (1.3 MB) | EPUB
  • 210 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia
Craig Speziali, Andrew Daly, Mohamed Abuhaleeqa, Janet Nitta, Yasser Abou Mourad, Matthew D. Seftel & Kristjan Paulson
Pages: 639-648
Published online: 30 Aug 2018
AbstractforFludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia | Full Text | References | PDF (981.9 KB) | EPUB | Supplemental
  • 698 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine–mitoxantrone–cyclophosphamide–alemtuzumab induction followed by alemtuzumab maintenance
Natali Pflug, Paula Cramer, Sandra Robrecht, Jasmin Bahlo, Anne Westermann, Anna-Maria Fink, Alexandra Schrader, Petra Mayer, Sebastian Oberbeck, Till Seiler, Thorsten Zenz, Jan Dürig, Karl-Anton Kreuzer, Stephan Stilgenbauer, Barbara Eichhorst, Michael Hallek, Marco Herling & Georg Hopfinger
Pages: 649-657
Published online: 20 Sep 2018
AbstractforNew lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine–mitoxantrone–cyclophosphamide–alemtuzumab induction followed by alemtuzumab maintenance | Full Text | References | PDF (793.6 KB) | EPUB | Supplemental
  • 607 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia
Sotirios G. Papageorgiou, Marios A. Diamantopoulos, Christos K. Kontos, Anthi Bouchla, Diamantina Vasilatou, Efthymia Bazani, Andreas Scorilas & Vasiliki Pappa
Pages: 658-667
Published online: 18 Jun 2018
AbstractforMicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 182 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Impact of earlier versus later monitoring on disease progression and healthcare costs among patients with chronic myeloid leukemia in the United States
Elias J. Jabbour, Lisa R. Siegartel, Jay Lin, Melissa Lingohr-Smith, Brandy Menges & Dinara Makenbaeva
Pages: 668-674
Published online: 20 Aug 2018
AbstractforImpact of earlier versus later monitoring on disease progression and healthcare costs among patients with chronic myeloid leukemia in the United States | Full Text | References | PDF (645.5 KB) | EPUB
  • 146 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study
Jan Walewski, Ewa Paszkiewicz-Kozik, Gabriela Borsaru, Andrzej Hellmann, Andrea Janikova, Agnieszka Warszewska, Anna Mais, Astrid Ammendola, Thomas Herz, Babett Krauss & Stefan W. Henning
Pages: 675-684
Published online: 30 Aug 2018
AbstractforResminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 233 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation
Céline M. Mürner, Frank Stenner-Liewen, Burkhardt Seifert, Nicolas J. Mueller, Adrian Schmidt, Christoph Renner, Urs Schanz, Alexander Knuth, Markus G. Manz, Michael Scharl, Bernhard Gerber & Panagiotis Samaras
Pages: 685-695
Published online: 21 Aug 2018
AbstractforEfficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation | Full Text | References | PDF (991.3 KB) | EPUB | Supplemental
  • 355 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Classical pediatric Hodgkin lymphoma in very young patients: the Italian experience
Piero Farruggia, Giuseppe Puccio, Francesco Locatelli, Mariarita Vetro, Marta Pillon, Angela Trizzino, Alessandra Sala, Salvatore Buffardi, Alberto Garaventa, Francesca Rossi, Maurizio Bianchi, Marco Zecca, Andrea Pession, Claudio Favre, Salvatore D’Amico, Massimo Provenzi, Giulio Andrea Zanazzo, Antonella Sau, Nicola Santoro, Rosamaria Mura, Caterina Elia, Tommaso Casini, Maurizio Mascarin & Roberta Burnelli
Pages: 696-702
Published online: 10 Oct 2018
AbstractforClassical pediatric Hodgkin lymphoma in very young patients: the Italian experience | Full Text | References | PDF (598.7 KB) | EPUB | Supplemental
  • 231 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Associations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome
Kiyomi Mashima, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Masahiro Ashizawa, Chihiro Yamamoto, Shinichiro Fujiwara, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi & Yoshinobu Kanda
Pages: 703-710
Published online: 06 Sep 2018
AbstractforAssociations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome | Full Text | References | PDF (1.1 MB) | EPUB
  • 150 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Long-term effect of all-trans retinoic acid and arsenic trioxide sequential maintenance in patients with acute promyelocytic leukemia
Shandong Tao, Chunling Wang, Yue Chen, Yuan Deng, Lixiao Song, Yuyue Shi, Lanlan Ling, Banghe Ding, Zhengmei He & Liang Yu
Pages: 711-719
Published online: 08 Nov 2018
AbstractforLong-term effect of all-trans retinoic acid and arsenic trioxide sequential maintenance in patients with acute promyelocytic leukemia | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 261 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study
Chezi Ganzel, Barbara Silverman, Daniel Chemtob, Assaf Ben Shoham & Yonit Wiener-Well
Pages: 720-725
Published online: 06 Sep 2018
AbstractforThe risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study | Full Text | References | PDF (763.6 KB) | EPUB | Supplemental
  • 263 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Augmented myeloablative conditioning with thiotepa in acute myeloid leukemia – improved outcomes with similar toxicity
Vipul Sheth, Boaz Nachmias, Sigal Grisariu, Batia Avni, Reuven Or & Michael Shapira
Pages: 726-733
Published online: 02 Oct 2018
AbstractforAugmented myeloablative conditioning with thiotepa in acute myeloid leukemia – improved outcomes with similar toxicity | Full Text | References | PDF (771.4 KB) | EPUB
  • 447 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP
Kento Umino, Shin-Ichiro Fujiwara, Daisuke Minakata, Chihiro Yamamoto, Akiko Meguro, Tomohiro Matsuyama, Kazuya Sato, Ken Ohmine, Tohru Izumi, Kazuo Muroi & Yoshinobu Kanda
Pages: 734-741
Published online: 06 Sep 2018
AbstractforPrognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP | Full Text | References | PDF (982.5 KB) | EPUB
  • 153 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Comparison of clinical features and survival between young and old chronic lymphocytic leukemia patients: a single center study from Turkey
Rafet Eren, Abdulkadir Karişmaz, Damla Karataş, Mehmet Hilmi Doğu, Şermin Altindal, Osman Yokuş & Elif Suyani
Pages: 742-747
Published online: 06 Sep 2018
AbstractforComparison of clinical features and survival between young and old chronic lymphocytic leukemia patients: a single center study from Turkey | Full Text | References | PDF (548.6 KB) | EPUB | Supplemental
  • 138 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†
Aleš Obr, Vit Prochazka, Tomas Papajik, Pavel Klener Jr., Andrea Janikova, David Salek, David Belada, Robert Pytlík, Alice Sykorova, Heidi Mocikova, Martin Simkovic, Vit Campr, Jitka Dlouha, Tomas Furst & Marek Trněný
Pages: 748-755
Published online: 06 Sep 2018
AbstractforMaintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry† | Full Text | References | PDF (1.1 MB) | EPUB
  • 329 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance
Dong-Yeop Shin, Jin-Kyun Park, Sung-Min Kim, Kyongok Im, Jung-Ah Kim, Sun Young Kim, Sang Mee Hwang, Sung-Soo Yoon & Dong-Soon Lee
Pages: 756-763
Published online: 10 Oct 2018
AbstractforASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 361 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?
Drorit Merkel, Shelly Soffer, Iliya Novikov, Abraham Avigdor, Ninette Amariglio, Arnon Nagler & Luba Trakhtenbrot
Pages: 764-771
Published online: 06 Sep 2018
AbstractforIs fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing? | Full Text | References | PDF (821.3 KB) | EPUB
  • 156 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Targeting the cross-talk between the hedgehog and NF-κB signaling pathways in multiple myeloma
Ke Cai, Wenxiu Na, Mengjie Guo, Ruirong Xu, Xinfeng Wang, Yi Qin, Yan Wu, Jie Jiang & Hongming Huang
Pages: 772-781
Published online: 15 Jan 2019
AbstractforTargeting the cross-talk between the hedgehog and NF-κB signaling pathways in multiple myeloma | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 245 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Sanguinarine suppresses growth and induces apoptosis in childhood acute lymphoblastic leukemia
Shilpa Kuttikrishnan, Kodappully S. Siveen, Kirti S. Prabhu, Abdul Quaiyoom Khan, Sabah Akhtar, Jericha M. Mateo, Maysaloun Merhi, Ruba Taha, Halima El Omri, Fatima Mraiche, Said Dermime & Shahab Uddin
Pages: 782-794
Published online: 06 Sep 2018
AbstractforSanguinarine suppresses growth and induces apoptosis in childhood acute lymphoblastic leukemia | Full Text | References | PDF (2.5 MB) | EPUB | Supplemental
  • 171 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia
Henning D. Popp, Johanna Flach, Susanne Brendel, Sabrina Ruppenthal, Helga Kleiner, Wolfgang Seifarth, Sven Schneider, Torsten J. Schulze, Christel Weiss, Frederik Wenz, Wolf-Karsten Hofmann & Alice Fabarius
Pages: 795-804
Published online: 31 Oct 2018
AbstractforAccumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia | Full Text | References | PDF (1.5 MB) | EPUB
  • 247 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Circulating microRNAs expression profile in newly diagnosed and imatinib treated chronic phase – chronic myeloid leukemia
Letícia Antunes Muniz Ferreira, Juliana Capannacci, Newton Key Hokama, Célia Regina Nogueira, Michele Ceccarelli, Luigi Cerulo, Fulvio D’Angelo & Paula de Oliveira Montandon Hokama
Pages: 805-811
Published online: 06 Sep 2018
AbstractforCirculating microRNAs expression profile in newly diagnosed and imatinib treated chronic phase – chronic myeloid leukemia | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 198 Views
  • 3 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
The role of radiotherapy in the management of primary cardiac lymphoma a case report and the literature review
Natalia Cichowska-Cwalińska, Magdalena Dutka, Andrzej Klapkowski, Rafał Pęksa, Jan Maciej Zaucha & Renata Zaucha
Pages: 812-816
Published online: 06 Sep 2018
First Page PreviewforThe role of radiotherapy in the management of primary cardiac lymphoma a case report and the literature review | Full Text | References | PDF (835.6 KB) | EPUB
  • 164 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
Wide-range effects of the MALT-1 inhibitor Mi-2 in CLL cells results in apoptosis
Nili Dezorella, Enosh Ashkenazi, Mika Shapiro, Chava Perry, Talia Kamdjou, Ben-Zion Katz & Yair Herishanu
Pages: 817-820
Published online: 04 Oct 2018
First Page PreviewforWide-range effects of the MALT-1 inhibitor Mi-2 in CLL cells results in apoptosis | Full Text | References | PDF (547.7 KB) | EPUB | Supplemental
  • 298 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Multiple isodicentric Y chromosomes in myeloid malignancies: a unique cytogenetic entity and potential therapeutic target
Abhishek A. Mangaonkar, Mrinal M. Patnaik, Gavin R. Oliver, Kathleen W. Rao, Kathleen Kaiser-Rogers, Jaime I. Davila, Numrah Fadra, Rebecca N. Wehrs, Michelle A. Elliott, Patricia T. Greipp, Kevin C. Halling & Daniel L. Van Dyke
Pages: 821-824
Published online: 30 Aug 2018
First Page PreviewforMultiple isodicentric Y chromosomes in myeloid malignancies: a unique cytogenetic entity and potential therapeutic target | Full Text | References | PDF (779.2 KB) | EPUB
  • 273 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
A rare MYC/BCL3 double-translocation and protein-expression in a diffuse large B-cell lymphoma
Hitoshi Ohno, Miho Nakagawa, Chiyuki Kishimori, Katsuhiro Fukutsuka, Masahiko Hayashida, Kiyotaka Izumi, Takashi Akasaka, Gen Honjo & Hironori Haga
Pages: 825-828
Published online: 06 Sep 2018
First Page PreviewforA rare MYC/BCL3 double-translocation and protein-expression in a diffuse large B-cell lymphoma | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 153 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies
Valentina Gianfelici, Monica Messina, Francesca Paoloni, Nadia Peragine, Alessia Lauretti, Anna Lucia Fedullo, Filomena Di Giacomo, Marco Vignetti, Antonella Vitale, Anna Guarini, Sabina Chiaretti & Robin Foà
Pages: 829-832
Published online: 06 Sep 2018
First Page PreviewforIL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies | Full Text | References | PDF (591.4 KB) | EPUB | Supplemental
  • 289 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma
Emanuele Cencini, Alberto Fabbri, Luana Schiattone & Monica Bocchia
Pages: 833-835
Published online: 20 Sep 2018
First Page PreviewforEfficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma | Full Text | References | PDF (333.9 KB) | EPUB
  • 198 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Most multiple myeloma patients have low testosterone
Sonya John, Nidhi Sharma, Douglas W. Sborov, Nita Williams, Desirée Jones, Don M. Benson, Yvonne A. Efebera, Ashley E. Rosko, Jennifer Vincent & Craig C. Hofmeister
Pages: 836-838
Published online: 02 Oct 2018
First Page PreviewforMost multiple myeloma patients have low testosterone | Full Text | References | PDF (533.3 KB) | EPUB | Supplemental
  • 209 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Prognostic impact of diagnosis to treatment interval (DTI) in diffuse large B-cell lymphoma patients: a real-life monocentric study
Vincent Camus, Sydney Dubois, Fabrice Jardin & Hervé Tilly
Pages: 839-841
Published online: 20 Sep 2018
First Page PreviewforPrognostic impact of diagnosis to treatment interval (DTI) in diffuse large B-cell lymphoma patients: a real-life monocentric study | Full Text | References | PDF (483.8 KB) | EPUB
  • 150 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Bilateral cystoid macular edema in a patient with chronic lymphocytic leukemia treated with ibrutinib
Manuel Saenz-de-Viteri & Tomas Cudrnak
Pages: 842-844
Published online: 06 Sep 2018
First Page PreviewforBilateral cystoid macular edema in a patient with chronic lymphocytic leukemia treated with ibrutinib | Full Text | References | PDF (574.4 KB) | EPUB
  • 316 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
A simple score based on geriatric assessment predicts survival in elderly newly diagnosed chronic lymphocytic leukemia patients
Stefano Molica, Diana Giannarelli, Luciano Levato, Rosanna Mirabelli, Domenico Levato, Mirella Lentini & Eugenio Piro
Pages: 845-847
Published online: 02 Oct 2018
First Page PreviewforA simple score based on geriatric assessment predicts survival in elderly newly diagnosed chronic lymphocytic leukemia patients | Full Text | References | PDF (401.7 KB) | EPUB | Supplemental
  • 190 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Frequent and reliable engraftment of certain adult primary acute lymphoblastic leukemias in mice
Birgitta Christine Heckl, Michela Carlet, Binje Vick, Catrin Roolf, Ameera Alsadeq, Michaela Grunert, Wen-Hsin Liu, Andrea Liebl, Wolfgang Hiddemann, Rolf Marschalek, Denis Martin Schewe, Karsten Spiekermann, Christian Junghanss & Irmela Jeremias
Pages: 848-851
Published online: 20 Sep 2018
First Page PreviewforFrequent and reliable engraftment of certain adult primary acute lymphoblastic leukemias in mice | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 225 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Myelofibrosis patients can develop extramedullary complications including renal amyloidosis and sclerosing hematopoietic tumor while otherwise meeting traditional measures of ruxolitinib response
Daria V. Babushok, Ernest J. Nelson, Jennifer J. D. Morrissette, Shivam Joshi, Matthew B. Palmer, Dale Frank, Carolyn L. Cambor & Elizabeth O. Hexner
Pages: 852-855
Published online: 19 Sep 2018
First Page PreviewforMyelofibrosis patients can develop extramedullary complications including renal amyloidosis and sclerosing hematopoietic tumor while otherwise meeting traditional measures of ruxolitinib response | Full Text | References | PDF (1.1 MB) | EPUB
  • 254 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years
Mariano Provencio, Fernando Franco, José Gómez-Codina, Cristina Quero Blanco, Marta Llanos, Francisco Garcia-Arroyo, Luis de la Cruz, Josep Gumá, Juan Ramón Delgado, Ruth Álvarez, José Ignacio Chacón, Ana Royuela & Antonio Rueda
Pages: 856-859
Published online: 20 Sep 2018
First Page PreviewforConsolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years | Full Text | References | PDF (500.4 KB) | EPUB
  • 208 Views
  • 4 CrossRef citations
  • 0Altmetric

Explore articles